site stats

Evofem earnings

WebNov 9, 2024 · As a result, net loss attributable to common stockholders was $29.9 million, or loss of $0.37 per share for the quarter ended September 30, 2024, as compared with … WebAug 4, 2024 · Welcome to the Evofem Biosciences' Q2 conference call. If you haven't done so already, I encourage you to access the Q2 2024 presentation and the press release …

EVFM : EVOFEM BIOSCIENCES, INC. - MSN Money

WebApr 12, 2024 · — Improves Phexxi coverage for more than 5.8 million New York lives — — Year-to-date, Evofem has gained Phexxi coverage for more than 22.1 million new lives — SAN DIEGO, April 12, 2024 ... WebApr 12, 2024 · Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York state that improves coverage for Phexxi® (lactic acid, citric acid and potassium bitartrate), its hormone-free ... culligan medicine hat alberta https://paulwhyle.com

Evofem Biosciences - EVFM Stock Forecast, Price & News - MarketBeat

WebAug 4, 2024 · Analysts expect Evofem Biosciences to report sales of $6.1 million, an increase of 226.88% over the same period last year. Analysts expect a loss of $9.013 … WebApr 15, 2015 · It gives me great pleasure to confirm the offer for your full-time, exempt employment with Evofem, Inc. as Chief Medical Officer. You will report directly to Evofem’s CEO. This term of employment will begin on June 1, 2015 at 50% time and salary from June 1, 2015 to June 30, 2015 based on an annual salary of $250,000.00. You will be full-time ... WebMay 04, 2024. $2.47. $1.66. -32.79%. Earnings announcements can affect a stock’s price. This table ... culligan medallist series water softener

Evofem Biosciences, Inc. (EVFM) Q3 2024 Earnings Call Transcript

Category:Offer Letter, dated as of April 15, 2015, by and between Evofem ...

Tags:Evofem earnings

Evofem earnings

Evofem Biosciences

WebGet the latest Evofem Biosciences Inc EVFM stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com. Top Stocks. Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. ... Evofem price target lowered to $2 from $30 at Piper Sandler Evofem price target lowered to $2 from $30 at Piper Sandler. WebAug 4, 2024 · Welcome to the Evofem Biosciences' Q2 conference call. If you haven't done so already, I encourage you to access the Q2 2024 presentation and the press release we issued earlier today, both of ...

Evofem earnings

Did you know?

WebNov 9, 2024 · Thank you for joining us this afternoon. In the second half of 2024 Evofem has achieved three significant milestones. In September, we launched Phexxi, the first and only non-hormonal prescription ... Web1 day ago · Look out for EVFM's next earnings release expected on March 02, 2024. For the next earning release, we expect the company to report earnings of -$0.15 per share, …

WebApr 11, 2024 · Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an … WebApr 10, 2024 · Evofem’s latest round of blood-letting will cut about $4.3 million in expenses, buying her company another few months of operating budget, while she keeps searching for a buyer or investor or ...

WebApr 11, 2024 · Evofem Biosciences Stock Earnings Report Current P/E ratio: -0.0018 Price (Apr 11, 2024, EOD): $0.0208 (Find current average P/E ratios for all sectors below … WebMay 7, 2024 · Evofem Biosciences, Inc. (OTCQB:EVFM) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ETCompany ParticipantsAmy Raskopf - Vice President of Investor RelationsSaundra Pelletier - Chief...

Web6 minutes ago · Evofem Biosciences, Inc., is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel.

WebEarnings. Loading ... Investor. Loading ... Financials. Loading ... Insiders. Loading ... Watchlist. Add. ... Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is ... culligan mineral boost cartridgeWebAbout Earnings Date. Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast … culligan military discountWebApr 6, 2024 · EVOFEM BIOSCIENCES, INC. company earnings calendar and analyst expectations - Upcoming and past events OTC Markets: EVFM OTC Markets ... Q1 2024 Earnings Release: 05/04/22 11:00am : Annual General Meeting: 03/31/22 : Academy of Managed Care Pharmacy Meeting: Past dividends on EVOFEM BIOSCIENCES, INC. culligan melbourneWeb6 minutes ago · Evofem Biosciences, Inc., is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. The … culligan mineral boost filterWebAug 11, 2024 · Shares of Evofem Biosciences (NASDAQ:EVFM) decreased 2.7% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 30.77% over the past year to ... culligan medallist water softener settingsWebMar 3, 2024 · Evofem Biosciences Inc. (EVFM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. culligan mid atlantic.comWebAug 4, 2024 · Evofem continues to expect net product sales in the range of $30 to $35 million for its 2024 fiscal year, representing 264% to 325% growth year-over-year. Gross … culligan mid atlantic